ANDRULIS PHARM CORP has a total of 16 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and machines are ASCENT PEDIATRICS INC, GUJU PHARM CO LTD and JSR LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | EPO (European Patent Office) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Andrulis Peter J Jr | 11 |
#2 | Andrulis Jr Peter J | 5 |
#3 | Drulak Murray W | 3 |
#4 | Angres Issac | 3 |
Publication | Filing date | Title |
---|---|---|
US5731325A | Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents | |
US5643915A | Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies | |
WO9504533A2 | Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents | |
AU7376394A | Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection | |
US5405855A | Treatment of insulin resistant diabetes with thalidomine | |
US5434170A | Method for treating neurocognitive disorders |